Post-COVID-19 disorder
MONDO:0100320A SARS-CoV-2-related disease that is caused by infection by SARS-CoV-2, and manifests after the original primary infection.
302 clinical trials for this condition and its sub-types, 107 tagged with Post-COVID-19 disorder itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Post-COVID-19 disorder
-
Long COVID-19 277 trials
-
Multisystem inflammatory syndrome in children and adults 1 trial · 7 incl. sub-types
-
Hope dashed: drug trial for Post-COVID racing heart stopped early
Disease control Stopped earlyThis study tested a drug called IgPro20 (HIZENTRA) to see if it could help people with post-COVID POTS, a condition that causes a rapid heart rate and dizziness when standing. The trial was stopped early after enrolling only 16 adults. The goal was to see if the drug could reduce…
Phase 3 • Sponsor: CSL Behring • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Experimental drug for Post-COVID POTS study halted early
Disease control Stopped earlyThis study looked at the long-term safety of efgartigimod in adults with post-COVID postural orthostatic tachycardia syndrome (POTS), a condition causing rapid heart rate and dizziness upon standing. The trial was an open-label extension for people who completed a previous study.…
Phase 2 • Sponsor: argenx • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Steroid trial for COVID brain fog halted early
Symptom relief Stopped earlyThis study tested whether the steroid methylprednisolone could improve memory and thinking in people with long COVID. About 96 adults with ongoing memory problems were to receive either the drug or a placebo for six weeks. The trial was terminated early, so we don't know if the t…
Phase 2 • Sponsor: Charite University, Berlin, Germany • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Pfizer mines insurance data to see if its vaccine stops long COVID
Knowledge-focused Stopped earlyThis study looks at anonymous health records from California and Louisiana to see if the Pfizer-BioNTech COVID-19 vaccine helps prevent post-COVID conditions (long COVID). Researchers will also track who gets vaccinated. The study includes adults with a COVID-19 diagnosis between…
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC